11.100.10 标准查询与下载

YY/T 1918-2023 数字聚合酶链反应分析系统

本文件规定了数字聚合酶链反应分析系统的分类，要求，试验方法，标签、标识和使用说明，包装、运输和贮存等内容。本文件适用于对核酸样本以单液滴或单核酸分子方式生成数百个至数百万个独立反应单元的设备，分析系统包括微液滴生成模块、聚合酶链反应模块和微滴检测模块等。

Digital polymerase chain reaction analysis system

GSO ISO 20184-1:2023 分子体外诊断检查 冷冻组织预检查过程规范 第1部分：分离RNA

This document gives guidelines on the handling, documentation, storage and processing of frozen tissue specimens intended for RNA examination during the pre-examination phase before a molecular assay is performed. This document is applicable to any molecular in vitro diagnostic examination performed by medical laboratories and molecular pathology laboratories that evaluate RNA extracted from frozen tissue. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organisations performing biomedical research, and regulatory authorities. Tissues that have undergone chemical stabilization pre-treatment before freezing are not covered in this document. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA

GSO ISO 20166-4:2023 分子体外诊断检查 福尔马林固定石蜡包埋（FFPE）组织预检查过程规范 第4部分：原位检测技术

This document specifies requirements and gives recommendations for the collection, handling, documentation, transport, storage and processing during the pre-examination phase of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for qualitative and/or (semi-)quantitative in situ examination of the morphology and of biomolecules, such as metabolites, proteins, DNA and/or RNA, on FFPE tissue sections by using different in situ detection techniques. This document is applicable to in vitro diagnostic examinations using in situ detection techniques. These include laboratory developed tests performed by pathology laboratories (histopathology laboratories) as well as by molecular pathology laboratories and other medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, as well as institutions and commercial organizations performing biomedical research, and regulatory authorities. This document is not applicable to the pre-examination phase of RNA, proteins and DNA isolated from FFPE tissue for examination. These are covered in ISO 20166-1, ISO 20166-2 and ISO 20166-3, Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for isolated RNA, proteins and DNA, respectively. Different dedicated measures are taken for pre-examination processes for fine needle aspirates (FNAs). These are covered in CEN WI 00140128, CEN WI 00140126, and CEN WI 00140129, Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) isolated cellular RNA, isolated proteins, and isolated genomic DNA, respectively. NOTE     International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for preexamination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 4: In situ detection techniques

GSO ISO 20184-3:2023 分子体外诊断检查 冷冻组织预检查过程规范 第3部分：分离DNA

This document specifies requirements and gives recommendations for the handling, storage, processing, and documentation of frozen tissue specimens intended for DNA examination during the pre-examination phase before a molecular examination is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories and molecular pathology laboratories that evaluate DNA isolated from frozen tissue. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. Tissues that have undergone chemical stabilization pre-treatment before freezing are not covered in this document. NOTE      International, national, or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 3: Isolated DNA

GSO ISO 20184-2:2023 分子体外诊断检查 冷冻组织预检查过程规范 第2部分：分离蛋白质 (ISO 20184-2:2018)

This document gives guidelines on the handling, documentation, storage and processing of frozen tissue specimens intended for the examination of isolated proteins during the pre-examination phase before a molecular assay is performed. This document is applicable to any molecular in vitro diagnostic examination performed by medical laboratories and molecular pathology laboratories that evaluate proteins isolated from frozen tissue. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organisations performing biomedical research, and regulatory authorities. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for frozen tissue - Part 2: Isolated proteins (ISO 20184-2:2018)

GSO ISO 20166-2:2023 分子体外诊断检查 福尔马林固定石蜡包埋 (FFPE) 组织预检查过程规范 第2部分：分离蛋白

This document gives guidelines on the handling, documentation, storage and processing of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for the examination of isolated proteins during the pre-examination phase before a molecular assay is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories and molecular pathology laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. This document is not applicable for protein examination by immunohistochemistry. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins

GSO ISO 23118:2023 分子体外诊断检查 尿液、静脉血清和血浆代谢组学预检查过程规范

This document specifies requirements and gives recommendations for the handling, documentation and processing of urine, venous blood plasma and serum intended for metabolomics analysis in the pre-examination processes. This document is applicable to metabolomics examinations and can be used by biomedical laboratories, customers of laboratories, in vitro diagnostics developers and manufacturers, institutions and companies performing biomedical research, biobanks, and regulatory authorities.

Molecular in vitro diagnostic examinations — Specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma

GSO ISO 20166-1:2023 分子体外诊断检查 福尔马林固定石蜡包埋（FFPE）组织预检查过程规范 第1部分：分离RNA

This document gives guidelines on the handling, documentation, storage and processing of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for RNA examination during the pre-examination phase before a molecular assay is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories and molecular pathology laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 1: Isolated RNA

GSO ISO 20166-3:2023 分子体外诊断检查 福尔马林固定石蜡包埋（FFPE）组织预检查过程规范 第3部分：分离DNA

This document gives guidelines on the handling, documentation, storage and processing of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for DNA examination during the pre-examination phase before a molecular assay is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories and molecular pathology laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA

YY/T 1883-2023 Rh血型C、c、E、e抗原检测卡（柱凝集法）

本文件规定了Rh血型C、c、E、e抗原检测卡（柱凝集法）的要求、试验方法、标签和使用说明书、包装、运输和贮存等。本文件适用于以凝胶、玻璃微珠等材料进行填充的微柱，微柱中抗C、c、E、e为IgM类型的单克隆抗体，采用免疫血液学、颗粒过筛和离心技术三者结合的原理，进行定性检测的Rh血型系统中C、c、E、e四种抗原的检测试剂。本文件不适用于血源筛查进行Rh血型C、c、E、e抗原检测的诊断试剂。

Rh blood group C, c, E, e antigen test card (column agglutination method)

YY/T 1789.5-2023 体外诊断检验系统 性能评价方法 第5部分：分析特异性

本文件规定了体外诊断检验系统的分析特异性性能评价方法。本文件适用于制造商对定量检验的体外诊断检验系统进行分析特异性评价、基于定量测量并通过阈值判断结果的定性体外诊断检验系统（例如酶联免疫吸附法的病原微生物抗原或抗体检测试剂盒）的分析特异性评价。本文件不适用于结果报告为名义标度和序数标度的体外诊断检验系统，例如用于血细胞鉴定、微生物鉴定、核酸序列鉴定、尿液颗粒鉴定体外诊断检验系统的性能评价。本文件不适用于医学实验室的性能验证，也不适用于产品型式检验。

Methods for performance evaluation of in vitro diagnostic test systems Part 5: Analytical specificity

YY/T 1882-2023 梅毒螺旋体抗体检测试剂盒（发光免疫分析法）

本文件规定了梅毒螺旋体抗体检测试剂盒（发光免疫分析法）的要求、试验方法、标识、标签和使用说明书、包装、运输和贮存。本文件适用于以夹心法或间接法为基本原理，使用化学发光免疫分析法、免疫荧光分析法、时间分辨免疫荧光分析法定性检测人血清和/或血浆中的梅毒螺旋体抗体。

Treponema pallidum antibody detection kit (luminescence immunoassay)

YY/T 1868-2023 乙型肝炎病毒核心抗体检测试剂盒（发光免疫分析法）

本文件规定了乙型肝炎病毒核心抗体检测试剂盒（发光免疫分析法）的技术要求、试验方法、标志、标签、使用说明书、包装、运输和贮存等。本文件适用于采用竞争法、间接法、夹心法原理，利用发光免疫分析技术，定性或定量检测人血清、血浆中乙型肝炎病毒核心抗体的试剂盒。包括化学发光、微粒子化学发光、电化学发光、光激化学发光和时间分辨荧光等方法。本文件不适用于：a)拟用于单独销售的乙型肝炎病毒核心抗体校准品和乙型肝炎病毒核心抗体质控品；b)以发光免疫分析为原理的生物芯片。

Hepatitis B virus core antibody detection kit (luminescence immunoassay)

YY/T 1199-2023 甘油三酯测定试剂盒（酶法）

本文件规定了甘油三酯测定试剂盒（酶法）的要求、试验方法、标识、标签和使用说明书、包装、运输和贮存等内容。本文件适用于基于分光光度法原理的甘油三酯测定试剂盒（酶法）的质量控制。

Triglyceride determination kit (enzymatic method)

YY/T 1789.6-2023 体外诊断检验系统 性能评价方法 第6部分：定性试剂的精密度、诊断灵敏度和特异性

本文件规定了体外诊断检验系统定性试剂的精密度、诊断灵敏度和特异性的性能评价方法。本文件适用于制造商对定性检验的体外诊断检验系统的精密度、诊断灵敏度和特异性评价。文件不适用于结果报告为半定量的体外诊断检验系统的性能评价。本文件不适用于医学实验室的性能验证，也不适用于产品型式检验。

In vitro diagnostic testing system performance evaluation methods Part 6: Precision, diagnostic sensitivity and specificity of qualitative reagents

YY/T 1870-2023 液相色谱-质谱法测定试剂盒通用要求

本文件规定了液相色谱-质谱法检测试剂盒的要求、试验方法、标签和使用说明书、包装、运输和贮存。本文件适用于以液相色谱-质谱法对人体样本（全血、血清、血浆、尿液等）进行定量检测的试剂盒。

General requirements for liquid chromatography-mass spectrometry assay kits

YY/T 1240-2023 D-二聚体测定试剂盒(免疫比浊法)

本文件规定了D-二聚体测定试剂盒（免疫比浊法）的要求、试验方法、标志、标签和使用说明书、包装、运输和贮存。本文件适用于免疫比浊法测定D-二聚体的试剂盒产品。

D-dimer assay kit (immune turbidimetric method)

DB37/T 4565-2022 远程动态心电诊断服务指南

Remote Holter Diagnosis Service Guide

YY/T 1880-2022 血清淀粉样蛋白A测定试剂盒

本文件规定了血清淀粉样蛋白A测定试剂盒的通用技术要求，包括要求、试验方法、标签和使用说明书、包装、运输和贮存。本文件适用于以抗原-抗体免疫反应为基本原理的定量测定人源样本中的血清淀粉样蛋白A的试剂盒，包括免疫比浊法、免疫层析法和化学发光免疫分析法试剂盒。本文件不适用于胶体金免疫层析法定量试剂盒。

Serum amyloid A assay kit

YY/T 1865-2022 BRCA基因突变检测试剂盒及数据库通用技术要求（高通量测序法）

本文件规定了BRCA基因突变检测试剂盒及数据库的试剂盒要求、数据库的数据构成、数据库的数据规范、数据库的数据管理和解读标准。本文件适用于BRCA基因胚系突变检测试剂盒、BRCA基因突变检测数据库和BRCA基因突变解读的质量控制。本文件不适用于BRCA基因体细胞突变检测以及双脱氧法（Sanger）对BRCA基因突变进行检测。

General technical requirements for BRCA gene mutation detection kits and databases (high-throughput sequencing method)